{"id":454021,"date":"2021-03-09T12:10:13","date_gmt":"2021-03-09T17:10:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454021"},"modified":"2021-03-09T12:10:13","modified_gmt":"2021-03-09T17:10:13","slug":"dr-katharine-knobil-named-agilents-first-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/","title":{"rendered":"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer"},"content":{"rendered":"

<\/p>\n

Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer<\/b><\/p>\n

SANTA CLARA, Calif.–(BUSINESS WIRE<\/a>)–
\nAgilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company\u2019s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company\u2019s presence in the health-care industry. As Agilent\u2019s first CMO, she will play a key role in the company\u2019s efforts to expand its leadership in precision medicine, supporting development of novel therapeutics to allow clinicians to identify appropriate patients and ultimately improve patient outcomes.\n<\/p>\n

This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210309005866\/en\/<\/a><\/p>\n

\"Dr.<\/p>\n

Dr. Kate Knobil, Agilent’s new chief medical officer. (Photo: Business Wire)<\/p>\n<\/div>\n

\n\u201cKate is an important addition to the Agilent team,\u201d said Mike McMullen, Agilent president and CEO. \u201cAs we see continued new developments in patient care and as Agilent products and services become increasingly essential to the health-care industry around the world, Kate\u2019s knowledge, experience and insights will be critical for us to achieve our objectives.\u201d\n<\/p>\n

\nKate Knobil has more than 20 years of experience in clinical development and medical affairs while serving in strategic leadership roles across the globe. She has led development and medical affairs functions in the U.S., Europe, and in emerging markets.\n<\/p>\n

\nPrior to joining Agilent, Knobil served as CMO and head of research and development at Kaleido Biosciences, where she applied her pharmaceutical-development experience to guide the company in its approach to translating the promise of the microbiome into solutions for patients. Knobil\u2019s prior experience also includes tenure at GlaxoSmithKline, where she served in a variety of leadership roles, including head of late-stage clinical development in China, head of value evidence and outcomes, and CMO. During her time with GlaxoSmithKline, she represented the company at multiple health-regulatory agencies in several countries and led presentations for eight U.S. Food and Drug Administration Advisory Committee Meetings.\n<\/p>\n

\nKnobil serves on the board of directors of Arena Pharmaceuticals Inc. and has served on the board of directors of the National Health Council. She received her bachelor\u2019s degree from Cornell University and her medical degree from the University of Texas Southwestern Medical School. She has also completed a fellowship in pulmonary and critical-care medicine at the Johns Hopkins University School of Medicine.\n<\/p>\n

\nKnobil will report directly to McMullen and will begin her role as Agilent\u2019s CMO in April.\n<\/p>\n

About Agilent Technologies<\/b><\/p>\n

\nAgilent Technologies Inc. (NYSE: A) is a global leader in the life-sciences, diagnostics, and applied-chemical markets, delivering insight and innovation toward advancing the quality of life. Agilent instruments, software, services, solutions, and people provide trusted answers to customers’ most challenging questions. The company generated revenue of $5.34 billion in fiscal year 2020 and employs 16,400 people worldwide. Information about Agilent is available at www.agilent.com<\/a>. To receive the latest Agilent news, please subscribe to the Agilent Newsroom<\/a>. Follow Agilent on LinkedIn<\/a>, Twitter<\/a>, and Facebook<\/a>.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210309005866\/en\/<\/a><\/span><\/p>\n

\nTom Beermann
\n
+1 408-553-2914
\n
tom.beermann@agilent.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Software Networks Hardware Electronic Design Automation Technology Semiconductor Nanotechnology Engineering Chemicals\/Plastics Biotechnology Manufacturing Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n
Photo<\/b><\/font><\/td>\n<\/tr>\n
\"Photo\"<\/td>\n<\/tr>\n
Dr. Kate Knobil, Agilent’s new chief medical officer. (Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company\u2019s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company\u2019s presence in the health-care industry. As Agilent\u2019s first CMO, she will play a key role in the company\u2019s efforts to expand its leadership in precision medicine, supporting development of novel therapeutics to allow clinicians to identify appropriate patients and ultimately improve patient outcomes. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210309005866\/en\/ Dr. Kate Knobil, Agilent’s new chief medical officer. (Photo: Business Wire) \u201cKate … <\/p>\n

Continue reading “Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454021","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nDr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company\u2019s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company\u2019s presence in the health-care industry. As Agilent\u2019s first CMO, she will play a key role in the company\u2019s efforts to expand its leadership in precision medicine, supporting development of novel therapeutics to allow clinicians to identify appropriate patients and ultimately improve patient outcomes. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210309005866\/en\/ Dr. Kate Knobil, Agilent’s new chief medical officer. (Photo: Business Wire) \u201cKate … Continue reading "Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-09T17:10:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20210309005866\/en\/863905\/4\/Knobil_Kate_16_ABN00049.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer\",\"datePublished\":\"2021-03-09T17:10:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/\"},\"wordCount\":568,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210309005866\\\/en\\\/863905\\\/4\\\/Knobil_Kate_16_ABN00049.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/\",\"name\":\"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210309005866\\\/en\\\/863905\\\/4\\\/Knobil_Kate_16_ABN00049.jpg\",\"datePublished\":\"2021-03-09T17:10:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210309005866\\\/en\\\/863905\\\/4\\\/Knobil_Kate_16_ABN00049.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20210309005866\\\/en\\\/863905\\\/4\\\/Knobil_Kate_16_ABN00049.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/","og_locale":"en_US","og_type":"article","og_title":"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer - Market Newsdesk","og_description":"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer SANTA CLARA, Calif.–(BUSINESS WIRE)– Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company\u2019s chief medical officer (CMO). The chief medical officer at Agilent is a newly created position designed to advise, lead, and elevate the company\u2019s presence in the health-care industry. As Agilent\u2019s first CMO, she will play a key role in the company\u2019s efforts to expand its leadership in precision medicine, supporting development of novel therapeutics to allow clinicians to identify appropriate patients and ultimately improve patient outcomes. This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20210309005866\/en\/ Dr. Kate Knobil, Agilent’s new chief medical officer. (Photo: Business Wire) \u201cKate … Continue reading \"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-09T17:10:13+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20210309005866\/en\/863905\/4\/Knobil_Kate_16_ABN00049.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer","datePublished":"2021-03-09T17:10:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/"},"wordCount":568,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210309005866\/en\/863905\/4\/Knobil_Kate_16_ABN00049.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/","name":"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20210309005866\/en\/863905\/4\/Knobil_Kate_16_ABN00049.jpg","datePublished":"2021-03-09T17:10:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20210309005866\/en\/863905\/4\/Knobil_Kate_16_ABN00049.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20210309005866\/en\/863905\/4\/Knobil_Kate_16_ABN00049.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dr-katharine-knobil-named-agilents-first-chief-medical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dr. Katharine Knobil Named Agilent\u2019s First Chief Medical Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454021"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454021\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}